Clinical Trial Update: Tranexamic Acid Usage in Bilateral Mastectomy to Reduce Post-surgical Drainage [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating tranexamic acid to reduce post-surgical drainage after bilateral mastectomy for breast cancer with BRCA mutation has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Northwestern University | Conditions: Breast Cancer, BRCA Mutation | Phase 2 | Status: WITHDRAWN